Endophthalmitis: Gram positive ethiological agents and susceptibility to glycopeptides

Current Clinical Pharmacology

Volumn 3, Issue 3, 2008, Pages 153-155

  Chisari, Guiseppe ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Endophthalmitis; Gram positive bacteria; Teicoplanin; Vancomycin

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT; GLYCOPEPTIDE;

ANAEROBIC BACTERIUM; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; BACILLUS; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG POTENCY; ENDOPHTHALMITIS; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENESIS; PEPTOCOCCUS; PRIORITY JOURNAL; PROPIONIBACTERIUM; REVIEW; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS; ARTICLE; DRUG EFFECT; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; BACILLUS; ENDOPHTHALMITIS; GLYCOPEPTIDES; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; PEPTOCOCCUS; STAPHYLOCOCCUS; STREPTOCOCCUS; TEICOPLANIN; VANCOMYCIN;

EID: 58149134966     PISSN: 15748847     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488408785747692     Document Type: Review

References (24)

1. Jeng BH, Kaiser PK, Lowder CY. Retinal vacsulitis and posterior pole "hypopyons" as early signs of acute bacterial endophthalmitis. Am J Ophthalmol 2001; 131: 800-2,
2. Hanscom TA. Postoperative endophthalmitis. Clin Infect Dis 2004; 38: 542-6.
3. Soriano ES, Nishi M. Endophthalmitis: incidence and prevention. Curr Opin Ophthalmol 2005; 16: 65-70.
4. Jensen MK, Fiscella RG, Crandall A.S, et al. A retrospective study of endophthalmitis rates comparing quinolone antibiotic. Am J Ophthalmol 2005; 139: 141-8.
5. Eifrig CW, Scott IU, Flynn HW Jr, Smiddy WE, Newton J. Endophthalmitis after pars plana vitrectomy: incidence, causative organism and visual acuity outcomes. Am J Ophthalmol. 2004; 138: 799-802.
6. Kodjikian L, Burillon C, Roques C, et al. Intraocular lenses, bacterial adhesion and endophthalmitis prevention: a review. Biomed Mater Eng 2004; 14: 395-409.
7. Li J, Morlet N, Ng JQ, Semmen JB, Knuiman MW, Team EPSWA. Significant nonsurgical risk factors for endophthalmitis after cataract surgery: EPSWA fourth report. Invest. Ophthalmol Vis Sci 2004; 45: 1321-8.
8. Chisari G, Accostano S, Reibaldi M Effect of aminoglycosides (Sub-MICs) on adherence of coagulase - negative staphylococci to intraocular lens surface J Chemother 2002; 14: 640-5.
9. Speaker MG, Milch FA, Shah MK, Eisner W, Kreiswirth BN. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 1991; 98: 639-49.
10. Endophthalmitis Vitrectomy Study Group. Results of the endophthalmitis vitrectomy study: a randomized trial of immediate vitrectomy and intravenous antibiotics for the treatment of post operative bacterial endophthalmitis. Arch Ophthalmol 1995; 113: 1479-96.
11. Garg SJ, Nelson M, Kanitkar K, Kleiner R. Subretinal abscess and endogenous endophthalmitis caused by beta-lactamase-positive Moraxella species. Retina 2006; 26: 968-9
12. Benz MS, Scott IU, Flynn HW, Unonius N, Miller D. Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol 2004; 137: 38-42.
13. Kunimoto DY, Das T, Sharma S, et al. Microbiologic Spectrum and susceptibility of isolates: Part I: Postoperative endophthalmitis. Am J Ophthalmol 1999; 128: 240-2.
14. Doft BH, Wisniewski SR, Kelsey. Diabetes and postoperative endophthalmitis in the endophthalmitis vitectomy study. Arch Ophthalmol 2001; 119: 650-6.
15. Hwu JJ, Chen KH, Hsu WM, Lai JY, Li YS. Ocular hypersensitivity to topical vancomycin in a case of chronic endophthalmitis. Cornea 2005; 24(6): 754-6
16. Briggs MC, McDonald P, Bourke R, et al. Intravitreal penetration of teicoplanin. Eye 1998; 12: 252-5.
17. National Committee for Clinical laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Sixth Edition M07-A6. NCCLS, Villanova, PA, USA, 2003.
18. National Committee for Clinical laboratory Standards. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard-Fifth Edition M11-A5. NCCLS, Villanova, PA, USA, 2001.
19. Haider SA, Hasset P, Bron AJ. Intraocular vancomycin levels and intravitreal injection in post cataract extraction endophthalmitis. Retina 2001; 21: 210-3.
20. Nucci C, Artini M, Pasmore M, Missiroli F, Costerton JW, Selan L. A microbiological and confocal microscopy study documenting a slime-producing Staphylococcus epidermidis isolated from a nylon corneal suture of a patient with antibiotic-resistant endophthalmitis. Graefes Arch Clin Exp Ophthalmol 2005; 243(9): 951-4
21. Ednie LM, Rattan A, Jacobs MR, Appelbaum PC. Antianaerobic activity of RBX 7644 (Ranbezolid), a new oxazolidinone, compared with those of eight other agents. Antimicrob. Agents Chemother. 2003; 47: 1143-7.
22. Citron DM, Merriam CV, Tyrrel KL, Warren YA, Fernandez H, Goldstein EJC. In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria. Antimicrob Agents Chemother 2003; 47: 2334-8.
23. Harding I, Sorgel F. Comparative pharmacokinetics of teicoplanin and vancomycin. J Chemother 2000; 12(Suppl 5): 15-20.
24. Carney M, Kao G, Peyman GA, Fiscella R, Staneck J. The intraocular penetration and retinal toxicity of teicoplanin. Ophthalmic Surg 1988; 19: 119-23.